Company Filing History:
Years Active: 2008
Title: Fred H. Rasmussen: Innovator in Matrix Metalloproteinase Activity Measurement
Introduction
Fred H. Rasmussen is a notable inventor based in Apex, NC (US). He has made significant contributions to the field of biomedical research, particularly in the measurement of matrix metalloproteinase (MMP) activities. His work has implications for diagnosing diseases and assessing disease severity.
Latest Patents
Fred H. Rasmussen holds a patent for "Assays for measuring matrix metalloproteinase activities." This patent describes methods for determining MMP activity in biological samples. The methods are useful for assessing disease severity or progression, diagnosing specific diseases, and developing profiles of MMP activity for inflammatory diseases such as arthritis and cancer. The invention involves using particular amino acid sequences in substrates to measure the activity of various MMPs, including collagenase 3, stromelysin 1, gelatinase A, gelatinase B, and collagenase 1. Additionally, a diagnostic kit for determining MMP activities in biological samples is provided.
Career Highlights
Fred H. Rasmussen is associated with Biozyme, Inc., where he applies his expertise in the development of diagnostic methods. His innovative approaches have contributed to advancements in the understanding of MMP activities and their relevance in various diseases.
Collaborations
Fred has collaborated with notable colleagues, including Marcia Moss and Michael Peter Vitek, to further enhance the research and development of diagnostic tools in his field.
Conclusion
Fred H. Rasmussen's work in measuring matrix metalloproteinase activities represents a significant advancement in biomedical diagnostics. His contributions continue to impact the understanding and treatment of inflammatory diseases and cancer.